BAGNOLI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 12.501
EU - Europa 7.206
AS - Asia 5.604
SA - Sud America 669
AF - Africa 125
OC - Oceania 91
Continente sconosciuto - Info sul continente non disponibili 1
Totale 26.197
Nazione #
US - Stati Uniti d'America 12.367
RU - Federazione Russa 2.720
SG - Singapore 1.661
CN - Cina 1.469
PL - Polonia 1.400
IT - Italia 780
HK - Hong Kong 775
IE - Irlanda 558
VN - Vietnam 535
BR - Brasile 525
SE - Svezia 498
KR - Corea 458
DE - Germania 339
FR - Francia 236
FI - Finlandia 205
IN - India 182
GB - Regno Unito 160
UA - Ucraina 102
AU - Australia 88
JO - Giordania 81
BD - Bangladesh 72
CA - Canada 71
ID - Indonesia 70
TR - Turchia 57
AR - Argentina 54
NL - Olanda 48
JP - Giappone 39
IQ - Iraq 38
MX - Messico 37
ES - Italia 35
PK - Pakistan 27
EC - Ecuador 25
ZA - Sudafrica 25
CI - Costa d'Avorio 22
BE - Belgio 18
CH - Svizzera 18
PH - Filippine 18
SA - Arabia Saudita 18
CO - Colombia 17
NG - Nigeria 13
CZ - Repubblica Ceca 12
MA - Marocco 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
KE - Kenya 11
AT - Austria 10
AZ - Azerbaigian 10
CL - Cile 10
VE - Venezuela 10
BG - Bulgaria 9
EG - Egitto 9
BJ - Benin 8
DZ - Algeria 8
IL - Israele 8
KG - Kirghizistan 8
KZ - Kazakistan 8
PE - Perù 8
PY - Paraguay 8
LT - Lituania 7
UY - Uruguay 7
JM - Giamaica 6
PT - Portogallo 6
TH - Thailandia 6
DK - Danimarca 5
GE - Georgia 5
GR - Grecia 5
IR - Iran 5
MY - Malesia 5
PA - Panama 5
TN - Tunisia 5
AL - Albania 4
LB - Libano 4
LV - Lettonia 4
NP - Nepal 4
RO - Romania 4
RS - Serbia 4
SC - Seychelles 4
SY - Repubblica araba siriana 4
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EE - Estonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
AO - Angola 1
BF - Burkina Faso 1
BW - Botswana 1
Totale 26.179
Città #
Santa Clara 2.261
Ashburn 1.502
Warsaw 1.396
Singapore 1.242
Fairfield 1.051
Hong Kong 666
Chandler 626
Dublin 555
Woodbridge 490
Seattle 462
Dallas 456
Cambridge 453
Seoul 452
Houston 431
San Jose 423
Wilmington 349
Beijing 335
Hefei 278
Altamura 244
Dearborn 216
Lawrence 215
Ann Arbor 204
Buffalo 163
Jacksonville 163
Ho Chi Minh City 156
Los Angeles 153
The Dalles 152
Princeton 145
Lauterbourg 142
Florence 127
Munich 124
Hanoi 119
Moscow 119
Council Bluffs 118
Mumbai 100
New York 99
Boston 97
Melbourne 86
Bremen 75
Boardman 74
Shanghai 65
Kent 63
Medford 62
San Diego 59
Helsinki 57
Jakarta 54
São Paulo 51
Orem 42
Turku 40
Izmir 39
Paris 39
London 37
Clifton 34
Frankfurt am Main 33
Tokyo 33
Chicago 30
Toronto 29
Rome 28
Chennai 24
Dong Ket 24
Montreal 24
Norwalk 23
Pune 23
Redondo Beach 23
Abidjan 22
Guangzhou 22
Milan 21
Yubileyny 21
Phoenix 20
San Francisco 20
Brooklyn 19
Hillsboro 19
Lappeenranta 19
Atlanta 18
Bengaluru 18
Brussels 18
Da Nang 18
Falls Church 18
Haiphong 18
Kunming 16
Stockholm 16
Tianjin 16
Denver 15
Johannesburg 15
Poplar 14
Abuja 13
Manchester 13
Nanjing 13
Rio de Janeiro 13
Andover 12
Bern 12
Tashkent 12
West Jordan 12
Biên Hòa 11
Curitiba 11
Jinan 11
Baghdad 10
Belo Horizonte 10
Campinas 10
Guayaquil 10
Totale 18.011
Nome #
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 327
Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts 311
Lipid Rafts Mediate Amyloid-induced Calcium Dyshomeostasis and Oxidative Stress in Alzheimer's Disease. 308
Membrane cholesterol enrichment prevents Abeta-induced oxidative stress in Alzheimer's fibroblasts. 300
Association Study of Genetic Variants in CDKN2A/CDKN2B genes/Loci with Late-Onset Alzheimer's Disease 288
Fat mass and obesity-associated gene (FTO) is associated to eating disorders susceptibility and moderates the expression of psychopathological traits 274
A Pilot Study Evaluating the Contribution of SLC19A1 (RFC-1) 80G>A Polymorphism to Alzheimer’s Disease in Italian Caucasians 274
Donor-specific anti-HLA antibodies in Huntington’s disease recipients of human fetal striatal grafts 268
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 256
Specific Silencing of L392V PSEN1 Mutant Allele by RNA Interference 255
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 245
Analyses of the role of the glucocorticoid receptor gene polymorphism (rs41423247) as a potential moderator in the association between childhood overweight, psychopathology, and clinical outcomes in Eating Disorders patients: A 6 years follow up study. 244
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 225
Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane 215
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 214
Association analysis of the paraoxonase-1 gene with Alzheimer's disease 212
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 212
A family with spinocerebellar ataxia type 8 expansion and vitamin E deficiency ataxia. 211
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 211
Ataxia-telangiectasia mutated (ATM) genetic variant in Italian centenarians 205
Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. 200
Association of the Variant Cys139Arg at GRN Gene to the Clinical Spectrum of Frontotemporal Lobar Degeneration 199
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 197
Association of IL10 promoter polymorphism in Italian Alzheimer's disease. 195
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 192
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 192
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 191
A new social-family model for eating disorders: A European multicentre project using a case-control design 190
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 189
Association between serotonin transporter gene polymorphism and eating disorders outcome: A 6-year follow-up study. 189
Identification of new presenilin gene mutations in early-onset familial Alzheimer disease 188
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 187
A Pan-European study of theC9orf72Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability and Intermediate Repeats 186
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 184
Biomarkers study in atypical dementia: proof of a diagnostic work-up 184
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 183
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease 182
Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation 181
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 180
PRESENILIN MUTATIONS LINKED TO FAMILIAL ALZHEIMER'S DISEASE REDUCE ENDOPLASMIC RETICULUM AND GOLGI APPARATUS CALCIUM LEVELS. 180
Implication of serotonin-transporter (5-HTT) gene polymorphism in subjective memory complaints and mild cognitive impairment (MCI). 179
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 178
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 178
Fragile X premutation with atypical symptoms at onset. 177
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 176
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 176
Intermediate alleles of HTT: A new pathway in longevity 175
Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. 174
Codon 129 polymorphism of prion protein gene in sporadic Alzheimer's disease. 174
Pattern and progression of cognitive decline in Alzheimer's disease:role of premorbid intelligence and ApoE genotype 174
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 173
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 172
Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity 172
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? 171
Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy. 171
Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons 171
Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease. 170
Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications. 170
Primary Progressive Aphasia: Natural History in an Italian Cohort 170
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 170
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia 169
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 169
Plasma Membrane Injury Depends on Bilayer Lipid Composition in Alzheimer’s Disease 167
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study 167
Clinical, Neurophysiological, and Genetic Predictors of Recovery in Patients With Severe Acquired Brain Injuries (PRABI): A Study Protocol for a Longitudinal Observational Study 166
Protective effect of new S-acylglutathione derivatives against amyloid induced oxidative stress 166
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 166
The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes 165
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 164
Implication of sex and SORL1 variants in italian patients with Alzheimer disease. 163
Glucocorticoid receptor gene polymorphisms in Italian patients with eating disorders and obesity. 162
Cholesteryl ester transfer protein (CETP) I405V polymorphism and longevity in Italian centenarians. 162
Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study. 161
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia 161
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 160
Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation 159
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 158
Brain metabolic differences between sporadic and familial Alzheimer's disease. 158
Amyloid cytotoxicity depends on membrane lipid composition in Alzheimer's disease 157
Clinical, Neurophysiological, and Genetic Predictors of Recovery in Patients With Severe Acquired Brain Injuries (PRABI): A Study Protocol for a Longitudinal Observational Study 157
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 157
Brain-derived neurotrophic factor genetic variants are notsusceptibility factors to Alzheimer's disease in Italy. 155
Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (Scientific Reports (2017) DOI: 10.1038/s41598-017-09320-z) 155
The urokinase-plasminogen activator (PLAU) gene is not associated with late onset Alzheimer's disease 153
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis 153
Alzheimer's disease: genetic basis and amyloid imaging as endophenotype 152
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 151
Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease. 151
Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease 151
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 150
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia 150
Parkinson-ALS with a novel MAPT variant 149
Insulin degrading enzyme and alpha-3 catenin polymorphisms in italian patients with Alzheimer disease 149
Psychopathological traits and 5-HT2A receptor promoter polymorphism (-1438 G/A) in patients suffering from Anorexia Nervosa and Bulimia Nervosa. 149
Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia 149
DAPK1 is Associated with FTD and not with Alzheimer's Disease 148
No association between the LRRK2 G2019S mutation and Alzheimer's disease in Italy. 148
Putative novel CSF biomarkers of Alzheimer’s disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort 147
Lack of association between NOS3 poly morphism and Italian sporadic and familial Alzheimer's disease. 147
Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 146
Totale 18.562
Categoria #
all - tutte 75.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 0 0 0 0 0 0 0 78 94
2021/2022996 30 77 104 25 16 47 46 77 44 41 192 297
2022/20232.750 262 604 110 294 162 458 350 131 272 17 63 27
2023/20241.066 52 105 159 52 84 117 60 233 30 62 69 43
2024/20257.106 228 789 529 1.102 1.873 1.007 86 404 311 207 262 308
2025/20268.252 929 1.188 1.051 765 1.085 350 1.042 436 541 612 253 0
Totale 26.400